Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohort
- PMID: 27301913
- PMCID: PMC5115980
- DOI: 10.1002/hep.28677
Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohort
Abstract
Chronic liver disease (CLD) and cirrhosis are major sources of morbidity and mortality in the United States. Little is known about the epidemiology of these two diseases in ethnic minority populations in the United States. We examined the prevalence of CLD and cirrhosis by underlying etiologies among African Americans, Native Hawaiians, Japanese Americans, Latinos, and whites in the Multiethnic Cohort. CLD and cirrhosis cases were identified using Medicare claims between 1999 and 2012 among the fee-for-service participants (n = 106,458). We used International Classification of Diseases Ninth Revision codes, body mass index, history of diabetes mellitus, and alcohol consumption from questionnaires to identify underlying etiologies. A total of 5,783 CLD (3,575 CLD without cirrhosis and 2,208 cirrhosis) cases were identified. The prevalence of CLD ranged from 3.9% in African Americans and Native Hawaiians to 4.1% in whites, 6.7% in Latinos, and 6.9% in Japanese. Nonalcoholic fatty liver disease (NAFLD) was the most common cause of CLD in all ethnic groups combined (52%), followed by alcoholic liver disease (21%). NAFLD was the most common cause of cirrhosis in the entire cohort. By ethnicity, NAFLD was the most common cause of cirrhosis in Japanese Americans, Native Hawaiians, and Latinos, accounting for 32% of cases. Alcoholic liver disease was the most common cause of cirrhosis in whites (38.2%), while hepatitis C virus was the most common cause in African Americans (29.8%).
Conclusions: We showed racial/ethnic variations in the prevalence of CLD and cirrhosis by underlying etiology; NAFLD was the most common cause of CLD and cirrhosis in the entire cohort, and the high prevalence of NAFLD among Japanese Americans and Native Hawaiians is a novel finding, warranting further studies to elucidate the causes. (Hepatology 2016;64:1969-1977).
© 2016 by the American Association for the Study of Liver Diseases.
Conflict of interest statement
the authors disclose no conflicts
Figures
Comment in
-
Changing epidemiology of chronic liver disease among ethnic groups in the United States.Hepatology. 2016 Dec;64(6):1843-1846. doi: 10.1002/hep.28783. Epub 2016 Oct 5. Hepatology. 2016. PMID: 27533477 No abstract available.
Similar articles
-
Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.Gastroenterology. 2015 Nov;149(6):1471-1482.e5; quiz e17-8. doi: 10.1053/j.gastro.2015.07.056. Epub 2015 Aug 5. Gastroenterology. 2015. PMID: 26255044
-
Diet Associations With Nonalcoholic Fatty Liver Disease in an Ethnically Diverse Population: The Multiethnic Cohort.Hepatology. 2020 Jun;71(6):1940-1952. doi: 10.1002/hep.30967. Epub 2020 Feb 14. Hepatology. 2020. PMID: 31553803 Free PMC article.
-
Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.).Ann Hepatol. 2023 Jul-Aug;28(4):101108. doi: 10.1016/j.aohep.2023.101108. Epub 2023 Apr 23. Ann Hepatol. 2023. PMID: 37088421
-
Nonalcoholic fatty liver disease in Asia: emerging perspectives.J Gastroenterol. 2017 Feb;52(2):164-174. doi: 10.1007/s00535-016-1264-3. Epub 2016 Sep 16. J Gastroenterol. 2017. PMID: 27637587 Review.
-
Nonalcoholic Fatty Liver Disease in Latinos.Clin Gastroenterol Hepatol. 2016 Jan;14(1):5-12; quiz e9-10. doi: 10.1016/j.cgh.2015.05.001. Epub 2015 May 11. Clin Gastroenterol Hepatol. 2016. PMID: 25976180 Review.
Cited by
-
Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis.Cochrane Database Syst Rev. 2019 Sep 12;9(9):CD013103. doi: 10.1002/14651858.CD013103.pub2. Cochrane Database Syst Rev. 2019. PMID: 31513287 Free PMC article.
-
Machine learning liver histology scores correlate with portal hypertension assessments in nonalcoholic steatohepatitis cirrhosis.Aliment Pharmacol Ther. 2023 Feb;57(4):409-417. doi: 10.1111/apt.17363. Epub 2023 Jan 17. Aliment Pharmacol Ther. 2023. PMID: 36647687 Free PMC article.
-
Racial and Ethnic Disparities in Lung Cancer Screening by the 2021 USPSTF Guidelines Versus Risk-Based Criteria: The Multiethnic Cohort Study.JNCI Cancer Spectr. 2022 May 2;6(3):pkac033. doi: 10.1093/jncics/pkac033. JNCI Cancer Spectr. 2022. PMID: 35642317 Free PMC article.
-
Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity.Aliment Pharmacol Ther. 2019 Jul;50(2):193-203. doi: 10.1111/apt.15316. Epub 2019 Jun 10. Aliment Pharmacol Ther. 2019. PMID: 31246368 Free PMC article.
-
Noninvasive Testing Using Magnetic Resonance Imaging Techniques as Outcomes in Nonalcoholic Steatohepatitis Clinical Trials: How Full Is the Glass?Hepatol Commun. 2020 Feb 3;4(2):141-144. doi: 10.1002/hep4.1473. eCollection 2020 Feb. Hepatol Commun. 2020. PMID: 32025600 Free PMC article. No abstract available.
References
-
- National Vital Statistics Reports 1999–2013: Centers for Disease Control and Prevention
-
- Nguyen GC, Thuluvath PJ. Racial disparity in liver disease: Biological, cultural, or socioeconomic factors. Hepatology. 2008;47:1058–1066. - PubMed
-
- Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H, Srishord M. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol. 2011;9:524–530. e521. quiz e560. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical